General University Hospital
Prague, 12000, Czechia
Location status: Recruiting
NCT Number: NCT06955377
The main mechanisms of airway protection include a properly functioning swallowing process and a cough. Studies focusing on patients with Parkinson's disease (PD) have previously demonstrated impairments in both swallowing (dysphagia) and coughing (dystussia). Aspiration pneumonia is the leading cause of death in individuals with PD.
Swallowing function is directly related to body posture. Postural abnormalities (PA) are a common symptom of PD and significantly contribute to patient disability, affect respiratory function, and reduce quality of life. Previous research has shown that more than 20% of PD patients suffer from some form of PA.
Most PD patients with a forward trunk flexion angle greater than 30 degrees report specific difficulties, such as dysphagia. A link has previously been demonstrated between postural abnormalities associated with flexed posture and restrictive ventilatory impairment. It can be assumed that this restrictive ventilatory impairment, which reduces the amount of air the patient can inhale into the lungs and subsequently exhale, negatively affects the strength of voluntary cough. However, this hypothesis has not yet been verified in the mentioned patient group.
The primary aim of the study will be to examine the effect of forward trunk flexion (FTF) in Parkinson's disease on the airway defense system.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Prague, 12000, Czechia
Location status: Recruiting
The primary aim of the study will be to verify the potential relationship between forward trunk flexion, respiratory muscle strength, and the strength of voluntary cough.
Hypotheses:
The secondary aim will be to correlate respiratory muscle strength and the strength of voluntary cough with handgrip strength and the pulmonary dysfunction index as potential screening methods.
Hypothesis:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: baseline, 12months, 24months, 36months
Assessments will be performed in accordance with American Thoracic Society/European Thoracic Society guidelines.
Time frame: baseline, 12months, 24months, 36months
Assessments will be performed in accordance with American Thoracic Society/European Thoracic Society guidelines.
Time frame: baseline, 12months, 24months, 36months
Assessments will be performed in accordance with American Thoracic Society/European Thoracic Society guidelines.
Time frame: baseline, 12months, 24months, 36months
Assessments will be performed in accordance with American Thoracic Society/European Thoracic Society guidelines.
Time frame: baseline, 12months, 24months, 36months
Assessments will be performed in accordance with American Thoracic Society/European Thoracic Society guidelines.
Time frame: baseline, 12months, 24months, 36months
The assessment of hand grip strength will be conducted according to the recommendations of the American Society of Hand Therapists. A digital hand dynamometer will be used.
Time frame: baseline, 12months, 24months, 36months
The screening assessment using the IPD questionnaire will involve the evaluation of four clinical indicators. The first two are direct questions asked to the patient regarding mucus management and cough strength. The third item is the strength of the voluntarily induced cough, subjectively assessed by the examiner. The fourth item tests the patient's ability to count out loud for as long as possible after a maximum inspiratory effort.
Contact information is provided by the study sponsor or research team.
Kateřina Dvořáková, MSc.
CONTACT
Martin Srp, PhD.
CONTACT
General University Hospital, Prague
Other
Effect of Forward Trunk Flexion in Patients With Parkinson's Disease on the Airway Defense System
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07207122
Basal Ganglia Diseases, Brain Diseases
Santa Monica, California, United States
View Trial DetailsNCT06680830
Basal Ganglia Diseases, Brain Diseases
Sun City, Arizona, United States
View Trial DetailsNCT07323121
Basal Ganglia Diseases, Brain Diseases
Nanjing, Jiangsu, China
View Trial DetailsNCT04477785
Anosmia, Basal Ganglia Diseases
Birmingham, Alabama, United States
View Trial Details